| |
| Issue |
Title |
| |
| Vol 18, No 3 (2022) |
Academicians and Corresponding Members of the Russian Academy of Science (Division of Medical Sciences) Elected by the General Meeting of Members of the Russian Academy of Science in June 1-3, 2022 |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 16, No 1 (2020) |
Report of the Editorial Board of the “Rational Pharmacotherapy in Cardiology” Journal about Work in 2019 |
Abstract
PDF (Rus)
|
|
E. K. Butina |
| |
| Vol 16, No 1 (2020) |
Free medications for treating cardiovascular disease in non-beneficiary patients |
Abstract
PDF (Rus)
|
|
Article Editorial |
| |
| Vol 15, No 6 (2019) |
Academicians and Corresponding Members of the Russian Academy of Science (Division of Medical Sciences) Elected by the General Meeting of Members of the Russian Academy of Science in November 14-15, 2019 |
Abstract
PDF (Rus)
|
|
Article Editorial |
| |
| Vol 15, No 6 (2019) |
Index of the Papers Published in the “Rational Pharmacotherapy in Cardiology” Journal in 2019 |
Abstract
PDF (Rus)
|
|
Article Editorial |
| |
| Vol 15, No 5 (2019) |
Findings Released from NAXOS Analysis. Pfizer Company Press Release |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 15, No 4 (2019) |
According to the AUGUSTUS Trial Apixaban (Eliquis ® ) was Found to Be Safer than Vitamin K Antagonists in Patients with Non-Valvular Atrial Fibrillation with Acute Coronary Syndrome and/or Percutaneous Coronary Intervention |
Abstract
PDF (Rus)
|
|
Company Pfizer |
| |
| Vol 15, No 1 (2019) |
XIII Russian Scientific Conference with International Participation “Rehabilitation and Secondary Prevention in Cardiology” May 21-22, 2019, Nizhny Novgorod |
Abstract
PDF (Rus)
|
|
article Editorial |
| |
| Vol 15, No 1 (2019) |
Report of the Editorial Board of the “Rational Pharmacotherapy in Cardiology” Journal about Work in 2018 |
Abstract
PDF (Rus)
|
|
E. K. Butina |
| |
| Vol 14, No 6 (2018) |
The Situation with Valsartan – Commentary of S.A. Boytsov, Chief Cardiologist of Ministry of Health of Russia for the Central, Urals, Siberian and Far Eastern Federal Districts |
Abstract
PDF (Eng)
|
|
artilce Editorial |
| |
| Vol 14, No 6 (2018) |
Professor S.A. Shalnova Received the Scopus Awards Russia 2018 as One of the Most Cited Scientists of the Russian Federation in the Healthcare Category |
Abstract
PDF (Eng)
|
|
artilce Editorial |
| |
| Vol 14, No 6 (2018) |
VIII International Forum of Cardiology and Internal Medicine, 27-29 March 2019, Moscow. Information letter |
Abstract
PDF (Eng)
|
|
artilce Editorial |
| |
| Vol 14, No 6 (2018) |
The Results of Rivaroxaban Studies COMMANDER HF and MARINER Were Published. Bayer Company Press Release . |
Abstract
PDF (Eng)
|
|
artilce Editorial |
| |
| Vol 14, No 5 (2018) |
Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA |
Abstract
PDF (Rus)
|
|
Bayer Company Press Release |
| |
| Vol 14, No 1 (2018) |
REPORT OF THE EDITORIAL BOARD OF THE “RATIONAL PHARMACOTHERAPY IN CARDIOLOGY” JOURNAL ABOUT WORK IN 2017 |
Abstract
PDF (Rus)
|
|
E. K. Butina |
| |
| Vol 13, No 6 (2017) |
INDEX OF THE PAPERS PUBLISHED IN THE “RATIONAL PHARMACOTHERAPY IN CARDIOLOGY” JOURNAL IN 2017 |
Abstract
PDF (Rus)
|
|
article editotial |
| |
| Vol 13, No 6 (2017) |
PREVALENCE OF HYPERURICEMIA AMONG PATIENTS WITH METABOLIC SYNDROME: RESULTS OF THE STUDY IN REAL CLINICAL PRACTICE |
Abstract
PDF (Rus)
|
|
D. V. Nebieridze, N. V. Dolgushina |
| |
| Vol 13, No 5 (2017) |
RIVAROXABAN OF THE BAYER COMPANY SIGNIFICANTLY (BY 24%) REDUCES THE RISK OF STROKE, CARDIOVASCULAR DEATH AND MYOCARDIAL INFARCTION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE OR PERIPHERAL ARTERIAL DISEASE |
Abstract
PDF (Rus)
|
|
статья Редакционная |
| |
| Vol 13, No 2 (2017) |
RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY |
Abstract
PDF (Rus)
|
|
. Editorial |
| |
| Vol 13, No 1 (2017) |
REPORT ON ACTIVITY OF THE EDITORIAL BOARD OF “RATIONAL PHARMACOTHERAPY IN CARDIOLOGY” IN 2016 |
Abstract
PDF (Rus)
|
|
E. K. Butina |
| |
| Vol 13, No 1 (2017) |
DATA OF THE RECENTLY PUBLISHED SWISS STUDY SWIVTER (THE SWISS VENOUS THROMBOEMBOLISM REGISTRY) DEMONSTRATE THE REPRODUCIBILITY OF THE RESULTS OF RANDOMIZED TRIALS IN REAL CLINICAL PRACTICE |
Abstract
PDF (Rus)
|
|
статья Редкционная |
| |
| Vol 12, No 6 (2016) |
INDEX OF THE PAPERS PUBLISHED IN THE “RATIONAL PHARMACOTHERAPY IN CARDIOLOGY” JOURNAL IN 2016 |
Abstract
PDF (Rus)
|
|
article editorial |
| |
| Vol 12, No 6 (2016) |
NEW DATA OF EXTENSIVE RESEARCH PROGRAM AND THE RESULTS OF STUDIES IN REAL CLINICAL PRACTICE FROM DIFFERENT COUNTRIES REAFFIRMED THE HIGH EFFICACY AND A FAVORABLE SAFETY PROFILE OF RIVAROXABAN (XARELTO®) FROM THE BAYER COMPANY PRESS RELEASE OF THE BAYER COMPANY |
Abstract
PDF (Rus)
|
|
article editorial |
| |
| Vol 12, No 6 (2016) |
ALL-RUSSIAN SCIENTIFIC AND PRACTICAL CONFERENCE "NON-COMMUNICABLE DISEASES AND THE HEALTH OF THE POPULATION OF RUSSIA", MAY 16-18, 2017, MOSCOW INFORMATION LETTER |
Abstract
PDF (Rus)
|
|
article editorial |
| |
| Vol 12, No 6 (2016) |
RAS ACADEMICIANS AND CORRESPONDING MEMBERS OF RAS ELECTED BY THE GENERAL MEETING OF MEMBERS OF RAS ON OCTOBER 27-28, 2016 BY DEPARTMENTS OF PHYSIOLOGY AND MEDICINE |
Abstract
PDF (Rus)
|
|
article editorial |
| |
| Vol 12, No 5 (2016) |
II Interregional Conference of Cardiologists and Internists, Ulyanovsk, 5-6 December 2016 Information letter |
Abstract
PDF (Rus)
|
|
Editorial article |
| |
| Vol 12, No 4 (2016) |
VI Caucasus scientific and educational conference of cardiology and internal medicine, 25-26 October, 2016. Information letter |
Abstract
PDF (Rus)
|
|
Article Editorial |
| |
| Vol 12, No 4 (2016) |
New data from clinical practice again confirmed the high efficacy and a favorable safety profile of the drug Xarelto® in patients with atrial fibrillation (Press release of the company Bayer) |
Abstract
PDF (Rus)
|
|
Article Editorial |
| |
| Vol 12, No 1 (2016) |
Report on activity of editorial board of “Rational Pharmacotherapy in Cardiology” in 2015 |
Abstract
PDF (Rus)
|
|
M. I. Smirnova |
| |
| 1 - 29 of 29 Items |
|
